Table 2.
Adiponectin levels based on the clinical characteristics of the AIS patients included in this study.
| Variable | N (%) | Adiponectin T1 Median (IQR) |
p-Value | Adiponectin T2 Median (IQR) |
p-Value | |
|---|---|---|---|---|---|---|
| Sex | Female | 27 (38.57) | 20.25 (15.55; 21.88) | 0.030 | 18.21 (14.32; 23.43) | 0.146 |
| Male | 43 (61.43) | 14.21 (11.58; 20.13) | 14.15 (11.66; 20.13) | |||
| Diabetes | No | 53 (78.47) | 16.55 (12.73; 21.28) | 0.442 | 16.04 (12.55; 22.54) | 0.942 |
| Yes | 15 (21.43) | 18.77 (13.34; 21.6) | 15.53 (13.76; 20.98) | |||
| Obesity (BMI ≥ 30 [kg/m2]) | No | 59 (86.76) | 17.42 (12.98; 21.75) | 0.034 | 16.98 (13.13; 24.02) | 0.038 |
| Yes | 9 (13.24) | 12.8 (8.42; 16.86) | 14.22 (9.39; 15.65) | |||
| Chronic alcohol use | No | 70 (85.71) | 16.44 (12.52; 21.08) | 0.280 | 15.37 (12.43; 22.34) | 0.375 |
| Yes | 10 (14.29) | 20.14 (13.3; 22.74) | 18.06 (14.35; 24.1) | |||
| Chronic smoker | No | 70 (85.71) | 16.8 (12.94; 21.23) | 0.494 | 16.04 (13.6; 22.47) | 0.468 |
| Yes | 10 (14.29) | 12.53 (9.76; 22.42) | 13.49 (10.54; 20.97) | |||
| Hypertension | grade 1 | 5 (7.14) | 15.34 (11.77; 16.33) | 0.771 | 14.31 (11.89; 26.67) | 0.537 |
| grade 2 | 24 (34.29) | 17.91 (10.74; 21.08) | 15.02 (12.21; 20.12) | |||
| grade 3 | 41 (58.57) | 16.74 (12.98; 21.4) | 17.48 (13.72; 23.15) | |||
| Stroke type | Cardioembolic | 27 (38.57) | 18.23 (13.55; 21.89) | 0.325 | 19.14 (14.53; 25.19) | 0.034 |
| Atherothrombotic | 43 (61.43) | 16.33 (11.47; 20.81) | 14.27 (11.75; 20.68) | |||
| Affected vascular territory |
Left middle cerebral artery | 32 (45.71) | 16.64 (11.62; 21.23) | 0.368 | 15.48 (12.61; 21.84) | 0.634 |
| Right middle cerebral artery | 24 (34.29) | 18.81 (14.03; 21.65) | 18.06 (13.74; 24.03) | |||
| Vertebrobasilar system | 14 (20) | 14.21 (12.78; 16.9) | 13.89 (12.48; 24.5) | |||
| Received thrombolysis |
No | 60 (85.72) | 16.46 (12.51; 21.1) | 0.104 | 15.59 (12.61; 22.34) | 0.382 |
| Yes | 10 (14.28) | 18.82 (14.74; 22.5) | 16.96 (13.49; 25.84) | |||
| NIHSS severity | ||||||
| At presentation | minor (NIHSS = 0–4) | 22 (31.43) | 17.14 (12.78; 21.6) | 0.098 | 14.86 (12.48; 26.27) | 0.589 |
| moderate (NIHSS = 5–15) | 28 (40) | 13.93 (11.54; 20.34) | 15.53 (12.22; 21.52) | |||
| moderate to severe (NIHSS ≥ 16) | 20 (28.57) | 19.1 (15.8; 22.5) | 16.04 (13.66; 24.88) | |||
| At 48 h | no stroke signs (NIHSS = 0) | 2 (2.86) | 17 (15.1; 18.89) | 0.520 | 14.42 (14.06; 14.78) | 0.834 |
| minor (NIHSS = 0–4) | 26 (37.14) | 16.1 (11.14; 21.6) | 14.59 (11.7; 25.93) | |||
| moderate (NIHSS = 5–15) | 27 (38.57) | 14.8 (12.28; 20.72) | 15.53 (13.02; 21.52) | |||
| moderate to severe (NIHSS ≥ 16) | 15 (21.43) | 19.43 (15.47; 21.89) | 16.51 (14.2; 23.26) | |||
| At discharge | no stroke signs (NIHSS = 0) | 12 (19.35) | 12.99 (11.04; 14.75) | 0.048 | 13.24 (9.45; 16.07) | 0.074 |
| minor (NIHSS = 0–4) | 27 (43.55) | 18.9 (12.8; 22.89) | 19.93 (14.25; 26.27) | |||
| moderate (NIHSS = 5–15) | 17 (27.42) | 14.57 (12.98; 16.55) | 13.99 (12.55; 19.39) | |||
| moderate to severe (NIHSS ≥ 16) | 6 (9.67) | 20.25 (17.11; 22.14) | 16.98 (15.3; 24.27) | |||
N: number of patients; IQR: interquartile range; BMI: body mass index; NIHSS: National Institutes of Health Stroke Scale; h: hours.